Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

ZEB2 and LMO2 Drive Immature T-Cell Lymphoblastic Leukemia Via Distinct Oncogenic Mechanisms

Steven Goossens, PhD, Jueqiong Wang, PhD, Cedric Tremblay, PhD, Pieter Van Vlierberghe, PhD, Geert Berx, PhD, Tom Taghon, PhD, Jody J Haigh, PhD

Blood (2018) 132 (Supplement 1): 3916.

https://doi.org/10.1182/blood-2018-99-111104

Published: 2018

Journal Articles

Oncogenic ZEB2 Activation Drives Sensitivity Towards LSD1 Inhibition in T-Cell Acute Lymphoblastic Leukemia

Steven Goossens, PhD, Sofie Peirs, MSc, Geert Berx, PhD, Pieter Van Vlierberghe, PhD, Jody J. Haigh, PhD

Blood (2016) 128 (22): 4027.

https://doi.org/10.1182/blood.V128.22.4027.4027

Published: 2016

Journal Articles

The EMT Modulator SNAI1 Drives AML Development Via Its Interaction with the Chromatin Modulator LSD1

Catherine L Carmichael, PhD, Steven Goossens, PhD, Jueqiong Wang, PhD, Thao Nguyen, PhD, Katharina Haigh, Geert Berx, PhD, Benjamin Kile, PhD, Jody J Haigh, PhD

Blood (2016) 128 (22): 2688.

https://doi.org/10.1182/blood.V128.22.2688.2688

Published: 2016

Journal Articles

Cyclin D2 Overexpression Recapitulates Mantle Cell Lymphoma in Mice

Tim Pieters, PhD, Steven Goossens, PhD, Sara T'Sas, Geert Berx, PhD, Jody J. Haigh, PhD, Pieter Van Vlierberghe, Prof

Blood (2016) 128 (22): 1748.

https://doi.org/10.1182/blood.V128.22.1748.1748

Published: 2016

Journal Articles

Zeb2-Defficiency in the Adult Murine Hematopoietic Precursor Cells Leads to Differentiation Defects in Multiple Hematopoietic Lineages and a Myeloproliferative-Like Phenotype

Tamara Riedt, Steven Goossens, PhD, Ines Gütgemann, MD, Carmen Carrillo-Garcia, PhD, Hichem D Gallala, PhD, Holger Fröhlich, PhD, Peter Brossart, MD, Dany Huylebroeck, PhD, Jody J Haigh, PhD, Viktor Janzen, MD

Blood (2012) 120 (21): 1199.

https://doi.org/10.1182/blood.V120.21.1199.1199

Published: 2012

NARROW

ZEB2 and LMO2 Drive Immature T-Cell Lymphoblastic Leukemia Via Distinct Oncogenic Mechanisms

Oncogenic ZEB2 Activation Drives Sensitivity Towards LSD1 Inhibition in T-Cell Acute Lymphoblastic Leukemia

The EMT Modulator SNAI1 Drives AML Development Via Its Interaction with the Chromatin Modulator LSD1

Cyclin D2 Overexpression Recapitulates Mantle Cell Lymphoma in Mice

Zeb2-Defficiency in the Adult Murine Hematopoietic Precursor Cells Leads to Differentiation Defects in Multiple Hematopoietic Lineages and a Myeloproliferative-Like Phenotype

Email alerts

ASH Publications

American Society of Hematology

ZEB2 and LMO2 Drive Immature T-Cell Lymphoblastic Leukemia Via Distinct Oncogenic Mechanisms

Oncogenic ZEB2 Activation Drives Sensitivity Towards LSD1 Inhibition in T-Cell Acute Lymphoblastic Leukemia

The EMT Modulator SNAI1 Drives AML Development Via Its Interaction with the Chromatin Modulator LSD1

Cyclin D2 Overexpression Recapitulates Mantle Cell Lymphoma in Mice

Zeb2-Defficiency in the Adult Murine Hematopoietic Precursor Cells Leads to Differentiation Defects in Multiple Hematopoietic Lineages and a Myeloproliferative-Like Phenotype

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only